Global Avian Influenza Vaccine Market

Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Strain(H5, H7), By Application(Chicken, Turkey) - Industry Forecast 2024-2031

Report ID: SQMIG35A2886 | Region: Global | Published Date: May, 2024
Pages: 215 | Tables: 63 | Figures: 70

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Avian Influenza Vaccine Market size was valued at USD 140.0 Billion in 2022 and is poised to grow from USD 145.88 Billion in 2023 to USD 202.74 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).

The competitive environment of the Avian Influenza Vaccine Market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. 'Boehringer Ingelheim International GmbH (Germany)', 'Guangdong Wenshi Dahuanong Biotechnology Co., Ltd (China)', 'Ceva (US)', 'Yebio Bioengineering Co., Ltd (China)', 'Zoetis (US)', 'FATRO S.P.A. (Italy)', 'CAVAC (South Korea)', 'Tianjin Ringpu Bio-Technology Co., Ltd (China)', 'PT Japfa Comfeed Indonesia Tbk (Indonesia)', 'Chengdu Tech-bank Biological Products Co., Ltd (China)', 'Merck Animal Health (US)', 'Medion (Indonesia)', 'Avimex Animal Health (Mexico)', 'JOVAC (Jordan)', 'QYH BIOTECH COMPANY LIMITED (China)'

Avian influenza can be defined as a disease caused by avian influenza virus type-A. This virus is commonly found in waterfowl and can infect domestic chickens and other bird species. Based on viral surface proteins, subtypes of influenza type A viruses can be classified into neuraminidase (NA) and hemagglutinin (HA). Based on their molecular characteristics and ability to cause disease and death in chicken avian influenza viruses are classified as highly pathogenic and low pathogenicity but both in poultry, high prevalence is reported. Nonpathogenic bird flu viruses show no signs of illness. Only mild diseases such as egg decline and wildflies show it. However, infection with the highly pathogenic influenza virus is associated with high mortality.

Along with Israel, China, India and South Korea have the highest number of bird flu viruses in Asia-Pacific. This is followed by rapid supply chain improvements and a growing R&D infrastructure through supportive government policies.

The avian influenza vaccine market is dominated by Asia Pacific. This can be attributed to increased poultry production and increasing outbreaks of bird flu in the region. China produced 13,900 thousand metric tons of poultry meat in 2022, according to a recent Foreign Agricultural Service/USDA report, it is estimated that the U.S. will exhibit significant market growth due to growing meat and poultry industry, increasing animal health expenditure.

Related Reports

Spinal Cord Stimulation Market
Buy Now GET FREE SAMPLE
Periodontal Scalers And Curettes Market
Buy Now GET FREE SAMPLE
Personal Emergency Response Systems (PERS) Market
Buy Now GET FREE SAMPLE
Medical Device Coating Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Avian Influenza Vaccine Market

Product ID: SQMIG35A2886

$5,300
BUY NOW